The Giessen-Bad Oeynhausen family study: Improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 8, 1999, Pages 496-505

  Jaeger, Clemens ^a,c   Hatziagelaki, E ^a   Stroedter, A ^a   Becker, F ^a   Scherer, S ^a   Petzoldt, R ^b   Federlin, K ^a   Bretzel, R G ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Autoimmunity; Family study; Islet autoantibodies; Prediabetes; Prediction

Indexed keywords

GLUTAMATE DECARBOXYLASE; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CHILD; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GERMANY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING;

EID: 0032724731     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1232558     Document Type: Article

References (35)

1. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK: Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 91: 350-356, 1993
2. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli , Richter-Olesen H, DeCamilli P: Identification of the 64K autoantigenin insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156, 1990
3. Becker F, Buschler H, Scherer S, Petzoldt H, Sauer H, Bretzel RG, Federlin K: Identifying the pre-diabetic state in type 1 diabetics: Condition for early intervention. J Autoimmun 3: 639-642, 1990
4. Bingley PJ, Bonifacio E, Gale EAM: Can we really predict IDDM? Diabetes 42: 213-220, 1993
5. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EAM: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody positive relatives. Diabetes 43: 1304-1310, 1994
6. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM: Prediction of IDDM in the general population -Strategies based on combinations of autoantibody markers. Diabetes 46: 1701-1710, 1997
7. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, Bottazzo GF: Quantification of islet cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147-149, 1990a
8. Bonifacio E, Boitard C, Gleichmann H, Shattock MA, Molenaar JL, Bottazzo GF: Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia 33: 731-736, 1990b
9. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E: Identification of tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 155: 5419-5426, 1995
10. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale EAM, Bosi E: Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38: 816-822, 1996
11. Christie MR, Roll U, Payton MA, Hatfield EC, Ziegler AG: Validity of screening for individuals at risk for type 1 diabetes by combined analysis of antibodies to recombinant proteins. Diab Care 20: 695-670, 1997
12. Cox DR: Regression models and life-tables. J R Stat Soc 34: 187-220, 1997
13. Dean BM, Becker F, McNally JM, Tarn AC, Schwartz G, Gale EAM, Bottazzo GF: Insulin autoantibodies in the prediabetic period: correlation with islet-cell antibodies and development of diabetes. Diabetologia 29: 339-342, 1986
14. Deschamps I, Boitard C, Hors J, Busson M, Marcelli-Barge A, Mogenet A, Robert JJ: Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. Diabetologia 35: 951-957, 1992
15. Dittler J, Seidel D, Schenker M, Ziegler AG: GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes 47: 592-597, 1998
16. Irvine WJ, Gray RS, McCallum CJ: Pancreatic islet-cell antibody as a marker for asymptomatic and latent diabetes and prediabetes. Lancet 2: 1097-1102, 1976
17. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
18. Kulmala P, Savola K, Petersen JS, Vahasalo P, Karjalainen J, Lopponen T, Dyrberg T, Akerblom HK, Knip M: Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 101: 327-336, 1998
19. Landin-Olsson M: Precision of the islet-cell antibody assay depends on the pancreas. J Clin Lab Anal 4: 289-294, 1990
20. Lernmark A, Molenaar JL, van Beers WA, Yamagucki Y, Nagataki S, Ludvigsson J, Maclaren NK: The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies: the Immunology and Diabetes Workshops and Participating Laboratories. Diabetologia 34: 534-535, 1991
21. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966
22. Marner B, Sernmark A, Nerup J, Molenaar JL, Tuk CW, Bruining GJ: Analysis of islet cell antibodies on frozen sections of human pancreas. Diabetologia 25: 93-96, 1986
23. Myers MA, Rabin DU, Rowley MJ: Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 44: 1290-1295, 1995
24. Payton MA, Hawkes CJ, Christie MR: Relationship of the 37.000 and 40.000 Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA 512). J Clin Invest 96: 1506-1511, 1995
25. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoir-Madsen M, Boel E, Michelsen B, Dyrberg T: Detection of GAD 65 antibodies in diabetes and other autoimmune disease using a simple radioligand assay. Diabetes 43: 459-467, 1994
26. Richter W, Endl J, Eiermann TH, Brandt M, Kientsch-Engel R, Thivolet C, Junfer H, Scherbaum WA: Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci USA 89: 8467-8471, 1992
27. Riley WJ, MacLaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, Schwartz S, Malone J, Shah S, Vadheim C, Rotter JL: A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323: 1167-1172, 1990
28. Roll U, Christie MR, Standl E, Ziegler AG: Association of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type 1 diabetic patients. Diabetes 43: 154-160, 1994
29. Savola K, Bonifacio E, Sabbah E, Kulmala P, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Meriläinen J, Akerblom HK, Knip M and the Childhood Diabetes in Finland Study Group: IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 41: 424-429, 1998
30. Schiffrin A, Colle E, Ciampi A, Hendricks L, Poussier P: Different rates of conversion to IDDM in siblings of type 1 diabetic children: The Montreal family study. Diab Res Clin Prac 21: 75-84, 1993
31. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA and the DENIS Study Group: Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 39: 1351-1356, 1996
32. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS: First-degree relatives of patients with Type I diabetes mellitus: islet-cell antibodies and abnormal insulin secretion. N Engl J Med 313: 461-464, 1985
33. Tarn A, Dean B, Schwarz G, Thomas J, Ingram D, Bottazzo GF: Predicting insulin-dependent diabetes. Lancet 1: 845-850, 1988
34. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 antoantibodies. Diabetes 45: 926-933, 1996
35. Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, Böhm BO, Richter W: Combined analysis and single-step detection of GAD 65 and IA2 antoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes 46: 565-571, 1997